Association of H-FABP with cardiovascular events: A systematic review.
Autor: | Parekumbel Venu A; Research Scholar, Meenakshi Academy of Higher Education and Research (MAHER-Deemed to be University), West K.K Nagar, Chennai, Tamil Nadu, India., Rajkumar R; Meenakshi Medical College Hospital & Research Institute, Meenakshi Academy of Higher Education and Research (MAHER-Deemed to be University), Kanchipuram, Tamil Nadu, India., Dinesh Roy D; Genetika Centre for Advanced Genetic Studies, Thiruvananthapuram, Kerala, India., Thekkumkara Prabhakaran S; Dr Moopen's Medical College, Wayanad, Kerala, India., Shankar K; Meenakshi Medical College Hospital & Research Institute, Meenakshi Academy of Higher Education and Research (MAHER-Deemed to be University), Kanchipuram, Tamil Nadu, India., Jayapal V; Hridayalaya Heart Foundation, Thiruvananthapuram, Kerala, India., Varalakshmi S; Meenakshi Medical College Hospital & Research Institute, Meenakshi Academy of Higher Education and Research (MAHER-Deemed to be University), Kanchipuram, Tamil Nadu, India., Sreenivasan S; Research Scholar, Meenakshi Academy of Higher Education and Research (MAHER-Deemed to be University), West K.K Nagar, Chennai, Tamil Nadu, India. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of cardiovascular and thoracic research [J Cardiovasc Thorac Res] 2024; Vol. 16 (2), pp. 77-87. Date of Electronic Publication: 2024 Jun 25. |
DOI: | 10.34172/jcvtr.33039 |
Abstrakt: | The research aimed to evaluate the association between heart-type fatty acid binding protein (H-FABP) and cardiovascular events. We systematically reviewed research that has been conducted to assess this relationship, aiming to determine how useful H-FABP could be as a biomarker for cardiovascular diseases, especially in the initial phases of acute myocardial infarction (AMI) and acute coronary syndrome (ACS). Our goal was to validate its diagnostic accuracy and clinical relevance. We systematically searched through PubMed, Web of Science, and Google Scholar databases to find pertinent publications related to cardiovascular diseases and H-FABP, using various permutations, abbreviations, and language variations of MeSH keywords. The final analysis included 12 studies in total. The final study comprised twelve studies, and it was concluded that H-FABP demonstrated high sensitivity (64.3-91.5) and specificity (73-100) for diagnosing Acute Myocardial Infarction (AMI) and Acute Coronary Syndrome (ACS), especially within the first hours of symptom onset. H-FABP demonstrates potential in enhancing the overall diagnostic accuracy during the initial hours following the manifestation of symptoms. However, the existing data do not provide sufficient evidence to recommend the regular utilization of H-FABP as a preliminary risk assessment approach in individuals who present with suspected cardiac events. Additional investigations, with well-defined prospective cohorts, are needed to validate the results observed. Competing Interests: Authors declare no conflict of interests in this study. (© 2024 The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |